Skip to main content

Table 1 Baseline characteristics at randomisation of women who participated in the RAVEL study and who did complete the W-DEQ antepartum and/or the W-DEQ postpartum

From: Pharmacological pain relief and fear of childbirth in low risk women; secondary analysis of the RAVEL study

 

W-DEQ antepartum (n = 374) n (%)

W-DEQ

postpartum (n = 315) n (%)

RAVEL

study n = 409 (%)

Gestational age (weeks), median [IQR]

36 [34–38]

36 [34–38]

36 [34–38]

Maternal age (years), mean (SD)

32 (4.1)

32 (4.0)

32 (4.1)

Randomisation allocation RAVEL trial

 Remifentanil-PCA

186 (50)

169 (54)

203 (50)

 Epidural analgesia

188 (50)

146 (46)

206 (50)

Ethnic origin

 Western

342 (91)

293 (93)

372 (91)

 Non Western

32 (9)

22 (7)

37 (9)

Education

 ≤ Low-medium professional school

75 (20)

53 (17)

81 (20)

 ≥ Higher professional school

288 (77)

253 (80)

314 (77)

 Unknown

11 (3)

9 (3)

14 (3)

Body mass index (kg/m2) mean (SD)

23 (3.4)

23 (3.4)

23 (3.4)

Parity

 0

262 (70)

222 (71)

284 (69)

 ≥ 1

112 (30)

93 (30)

125 (31)

Pain relief requested

 No

186 (50)

157 (50)

203 (50)

 Yes

188 (50)

158 (50)

206 (50)

Pain relief received

 No

219 (59)

185 (59)

239 (58)

 Yes

155 (41)

130 (41)

170 (42)

  Remifentanil-PCA

80 (21)

72 (23)

94 (23)

  Epidural analgesia

72 (19)

55 (18)

76 (19)

  Other (opioid)

3 (1)

3 (1)

3 (1)

W-DEQ score (level of fear of childbirth)

 < 85 (low-medium fear of childbirth)

342 (91)

278 (88)

 ≥ 85 and < 100 (intense fear of childbirth)

30 (8)

26 (8)

 ≥ 100 (very intense/fobic fear of childbirth)

2 (1)

11 (4)

  1. IQR interquartile range, SD standard deviation